Population Health

The clinical manifestations of COVID-19 are varied, and patients are known to have rapidly changing signs and symptoms that must be tracked with laboratory testing.

Data science and clinical teams at PCCI, in collaboration with Parkland informaticists, have developed an AI-driven predictive model that predicts for individual COVID-19 exposure risk, based on population density and their proximity to positive cases.

COVID-19 has revealed a lot about the world we live in. It has reinforced the possibilities that open up when we collaborate and come together, united towards a common cause; in this case, of defeating the spread of SARS-CoV-2 says Atif Al Braiki, CEO, Abu Dhabi Health Data Services LLC (Malaffi).

One of the more remarkable features of the NHS’s response to the coronavirus pandemic has been its rapid uptake of technology in the UK says director of international relations at NHS Confederation, Dr Layla McCay.

How healthcare providers can leverage interoperability across the care continuum for improved care coordination and patient empowerment. 

More than ever, the system selected to provide telemedicine services must provide added controls to overcome factors that are outside the control of the provider.

Health and care have been inexorably moving toward a new paradigm – one where the nature of the interactions is more personalised and they require the person to be more active in their pursuit of reducing risks that have an adverse effect upon the development of non-communicable diseases, says Dr Charles Alessi, chief clinical officer at HIMSS.

Michael Seres was an entrepreneur, patient advocate, husband and father of three. He died on 30 May 2020, in California, US, of a sepsis infection. This news not only shook the patient community, but also the global healthcare IT space.

A healthcare system in which stakeholders share, adopt and apply medical knowledge in real time enables improved care, accelerated workflows, streamlined business processes and a better balance of resources with demand.

Without cross-border co-operation the potential of personalised health cannot be realised, acccording to Bogi Eliasen, director at the Health Copenhagen Institute for Futures Studies and HIMSS Future50 leader, who will be speaking at HIMSS & Health 2.0 European Digital Event taking place 7-11 September.